Coenzyme Q10 (Ubiquinone)
Dr.
Frederick Crane isolated this orange-colored powder from beef
heart in 1957. The next year Dr. Karl Folkers, then a research
scientist at Merck, identified Coenzyme Q10's molecular
structure. When a professor at the University of Texas, Dr.
Folkers was the most prominent advocate for using Coenzyme Q10
to treat congestive heart failure and other diseases. Although
scientists show considerable interest in Coenzyme Q10, most
practicing physicians are not aware of its potential.
In Japan and other countries, coenzyme
Q10 (CoQ10) is an approved treatment for several
cardiovascular conditions. Considerable evidence suggests that
it may be useful in treating congestive heart failure as well
as other heart conditions. For these purposes, it is often
combined with conventional medications. CoQ10 has also been
proposed as a treatment for high blood pressure.
One small Japanese study found that
angina patients given Coenzyme Q10 felt better and had
improved results on a stress test compared to patients given a
placebo. An encouraging result which needs to be repeated
before a conclusion can be made.
CoQ10 was first identified as an
orange-colored substance present in heart muscle cells of
cows. Eventually, it was found to exist in many human organs,
including the heart, kidney, liver, and pancreas. It is made
by the body and also is ingested from foods such as meats,
fish, and soybean oil. It turns out that CoQ10 helps cells
turn food into energy, so it's found almost everywhere in your
body. For that reason, it's also called ubiquinone, a name
derived from the word ubiquitous (existing everywhere). Since
the body can synthesize CoQ10 from other substances, it is not
classified as an essential nutrient.
CoQ10 has antioxidant effects, working
like vitamin E to neutralize free radicals and thus prevent
the cell damage caused by them.8 It may also help recycle
used-up vitamin
It's been suggested that CoQ10 may lower
your blood pressure by reducing the resistance of blood
vessels to the flow of blood. However, there is little actual
research evidence. Most of the studies performed lacked a
control group.
One placebo-controlled trial of CoQ10
has been performed, but it was very small, involving only 18
hypertensive patients.10 They received either 100 mg of CoQ10
daily or placebo for 10 weeks. In the CoQ10 patients, systolic
and diastolic pressures fell by 10.6 mm and 7.7 mm,
respectively. The placebo group showed no changes in blood
pressure. These are promising results that need to be
confirmed in larger studies.
In a small non-placebo trial, 26 people
with hypertension received a 50-mg dose of CoQ10 twice a day
for 10 weeks. The results showed about a 10% improvement in
blood pressure.11 Another non-placebo trial of 109 patients
treated with CoQ10 also showed a significant improvement in
blood pressure over a period of 1 to 6 months.12 However,
because many studies have shown that even placebo pills can
lower blood pressure (as well as inspire participants to make
lifestyle improvements), we really need double-blind
placebo-controlled trials to know whether CoQ10 really works.
As promising as CoQ10 supplementation
might seem, the research evidence for its blood
pressure-lowering effects must be regarded as preliminary
only.
The dose of CoQ10 for treating
hypertension, congestive heart failure, and other conditions
has been 30 to 150 mg daily or more, divided into two or three
doses at the higher levels. Duration of therapy has lasted as
long as 6 years. CoQ10 is fat-soluble and is better absorbed
when taken in oil-based soft-gel form rather than in a dry
form such as tablets and capsules.
No serious side effects have been
reported with CoQ10 therapy. Infrequent side effects have
included gastrointestinal discomfort, nausea, diarrhea, and
appetite loss. But since it's been studied only in small
trials, we can't be certain it's entirely safe.
HMG-CoA reductase inhibitors—such as the
lipid-lowering statin drugs may lower body levels of CoQ10 and
lead to a deficiency in it.
Taking supplemental CoQ10 may be a good
idea if you are taking one of these medications. Drug
interaction studies have not been done. Maximum safe doses in
young children, pregnant or breast-feeding women, or those
with severe liver or kidney disease have not been established.
Co-Enzyme Q10 Articles and
Studies
Study 1
Overview
of the use of CoQ10 in cardiovascular
disease
Study 2
Effective
and safe therapy with coenzyme Q10 for
cardiomyopathy.
Study 3
Effective
treatment with coenzyme Q10 of patients with chronic
myocardial disease
Study 4
Therapy
with coenzyme Q10 of patients in heart failure who are
eligible or ineligible for a transplant.
Study 5
A
six-year clinical study of therapy of cardiomyopathy with
coenzyme Q10.
Study 6
Pronounced
increase of survival of patients with cardiomyopathy when
treated with coenzyme Q10 and conventional
therapy.